SB
DNA icon

Strategic Blueprint’s Ginkgo Bioworks DNA Stock Holding History

Strategic Blueprint’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-250
Closed -$3.34K – 662
2024
Q2 		$3.34K Hold
250
– – ﹤0.01% 610
2024
Q1 		$11.6K Hold
250
– – ﹤0.01% 601
2023
Q4 		$16.9K Hold
250
– – ﹤0.01% 552
2023
Q3 		$18.1K Buy
+250
New +$20K ﹤0.01% 521

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Strategic Blueprint's DNA Position: Q3 2024 in Review

Strategic Blueprint sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 250 shares — an estimated $3.34K sold.

Strategic Blueprint first reported a position in DNA in Q3 2023 and held it in 4 quarters. The position peaked at $18.1K in Q3 2023. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Strategic Blueprint reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Strategic Blueprint sold 250 Ginkgo Bioworks shares in Q3 2024, an estimated $3.34K.
  • Strategic Blueprint first reported a position in Ginkgo Bioworks in Q3 2023 and held it in 4 quarters.
  • Strategic Blueprint's Ginkgo Bioworks position peaked at $18.1K in Q3 2023.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Strategic Blueprint's 13F filing for Q3 2024, filed 25 Oct 2024.